Description

This is a screening test that quantifies microalbumin from the first urine in the morning or random concentrated urine to check the extent of kidney damage and predict the progression to kidney failure. Continuous measurement of microalbumin concentration can help patients receive appropriate treatment and confirm treatment effects.